Gray Cameron 4
4 · Cue Biopharma, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Exercise of In-Money
Warrants
2022-06-14−61,111→ 0 totalExercise: $2.70From: 2015-06-15Exp: 2022-06-15→ Common Stock (61,111 underlying) - Tax Payment
Common Stock
2022-06-14$3.20/sh−51,562$164,998→ 687,049 total - Exercise of In-Money
Common Stock
2022-06-14$2.70/sh+61,111$165,000→ 738,611 total
Footnotes (1)
- [F1]On June 14, 2022, the reporting person exercised a warrant to purchase 61,111 shares of the Issuers common stock for $2.70 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Issuer withholding of 51,562 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 9,549 shares.